ACHE and Alzheimer disease: In AD patients, dysfunction of the cholinergic system is evidenced by increased activity of AChE, an important enzyme that hydrolyses acetylcholine (ACh), an essential neurotransmitter implicated in memory and learning; so, we therefore investigated the AChE-inhibitory effect of canagliflozin.